Ischemic Pain Control With Analgesic Methods Clinical Trial (ISCHAEMIC)
Primary Purpose
Arterial Occlusive Diseases
Status
Unknown status
Phase
Phase 3
Locations
Study Type
Interventional
Intervention
Continuous peripheral sciatic nerve block
Fentanyl
Ropivacaine
Perineural catheter
Sponsored by
About this trial
This is an interventional treatment trial for Arterial Occlusive Diseases
Eligibility Criteria
Inclusion Criteria:
- Patients older than 18 years old who have strong or moderate persistent ischemic pain in the lower limbs, due to peripheral artery occlusive disease, classified as Fontaine IV (pain at rest and presence of ulcer or gangrene).
Exclusion Criteria:
- Uncooperative patients, coagulation disorders, patients with liver failure, who have atrioventricular block second or third degree, who refuse to be submitted to peripheral nerve block, with systemic or procedure site local infection infection, peripheral or central neuropathy history, allergies to local anesthetics or to any of the drugs to be used in the study and difficulty in understanding the use of the PCA (patient-controlled analgesia) device and evaluation methods used in the study .
Sites / Locations
Arms of the Study
Arm 1
Arm 2
Arm Type
Active Comparator
Active Comparator
Arm Label
Continuous nerve block
Systemic analgesia
Arm Description
Continuous peripheral sciatic nerve block through popliteal perineural catheter with ropivacaine
Intravenous fentanyl patient controlled analgesia device
Outcomes
Primary Outcome Measures
Pain intensity
Verbal numerical scale
Secondary Outcome Measures
Opioids Adverse effects
Nausea, vomiting, constipation, sedation
Full Information
NCT ID
NCT02841488
First Posted
July 17, 2016
Last Updated
July 21, 2016
Sponsor
University of Sao Paulo General Hospital
1. Study Identification
Unique Protocol Identification Number
NCT02841488
Brief Title
Ischemic Pain Control With Analgesic Methods Clinical Trial
Acronym
ISCHAEMIC
Official Title
Comparative Study Between Systemic Analgesia and Continuous Sciatic Nerve Block in Patients With Chronic Obstructive Arterial Disease and Ischemic Pain in Lower Limbs
Study Type
Interventional
2. Study Status
Record Verification Date
July 2016
Overall Recruitment Status
Unknown status
Study Start Date
September 2016 (undefined)
Primary Completion Date
September 2018 (Anticipated)
Study Completion Date
October 2018 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
University of Sao Paulo General Hospital
4. Oversight
Data Monitoring Committee
No
5. Study Description
Brief Summary
This project is one of four components of a thematic project that aims to evaluate the use of ultrasound in regional blocks, called "Use of ultrasound in regional blocks and injections for the treatment of acute and chronic pain."
It will evaluate quantitative and qualitative control of ischemic pain in the lower limbs in patients with peripheral arterial occlusive disease through continuous sciatic nerve block by perineural catheter, popliteal approach, compared to systemic analgesia based on opioids.
Detailed Description
BACKGROUND: Peripheral arterial occlusive disease (PAOD) commonly evolves with intense ischemic pain in the lower limbs, which is hard to control with systemic analgesics, and continuous regional anesthesia may be an alternative, with adequate analgesia and lower incidence of side effects.
OBJECTIVES: evaluate qualitative and quantitative pain control, incidence of adverse effects and operative results in patients with PAOD undergoing continuous anesthetic blockade of the sciatic nerve by perineural catheter compared to systemic analgesia based on opioids and adjuvant medications.
METHODS: It is a randomized clinical trial, covered for evaluators. It will include 56 patients with PAOD Fontaine IV, with pain by the presence of ulcerations located on foot. A group will be submitted to continuous regional anesthesia of sciatic nerve through perineural catheter and another group will have its pain control through patient controlled analgesia device with intravenous fentanyl. The primary dependent variable will be pain, through the numerical pain scale.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Arterial Occlusive Diseases
7. Study Design
Primary Purpose
Treatment
Study Phase
Phase 3
Interventional Study Model
Parallel Assignment
Masking
Outcomes Assessor
Allocation
Randomized
Enrollment
56 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
Continuous nerve block
Arm Type
Active Comparator
Arm Description
Continuous peripheral sciatic nerve block through popliteal perineural catheter with ropivacaine
Arm Title
Systemic analgesia
Arm Type
Active Comparator
Arm Description
Intravenous fentanyl patient controlled analgesia device
Intervention Type
Procedure
Intervention Name(s)
Continuous peripheral sciatic nerve block
Other Intervention Name(s)
Perineural sciatic catheter
Intervention Description
Continuous infusion of local anesthetics through perineural sciatic nerve catheter
Intervention Type
Drug
Intervention Name(s)
Fentanyl
Other Intervention Name(s)
Intravenous fentanyl
Intervention Description
Use of patient controlled analgesia device with intravenous fentanyl
Intervention Type
Drug
Intervention Name(s)
Ropivacaine
Intervention Type
Device
Intervention Name(s)
Perineural catheter
Primary Outcome Measure Information:
Title
Pain intensity
Description
Verbal numerical scale
Time Frame
up to 28th day
Secondary Outcome Measure Information:
Title
Opioids Adverse effects
Description
Nausea, vomiting, constipation, sedation
Time Frame
up to 28th day
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Patients older than 18 years old who have strong or moderate persistent ischemic pain in the lower limbs, due to peripheral artery occlusive disease, classified as Fontaine IV (pain at rest and presence of ulcer or gangrene).
Exclusion Criteria:
Uncooperative patients, coagulation disorders, patients with liver failure, who have atrioventricular block second or third degree, who refuse to be submitted to peripheral nerve block, with systemic or procedure site local infection infection, peripheral or central neuropathy history, allergies to local anesthetics or to any of the drugs to be used in the study and difficulty in understanding the use of the PCA (patient-controlled analgesia) device and evaluation methods used in the study .
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Hermann S Fernandes, MD
Phone
+55 84 988966348
Email
hermann.fernandes@hc.fm.usp.br
First Name & Middle Initial & Last Name or Official Title & Degree
Hazem A Ashmawi, PhD
Phone
+55 11 985733798
Email
hazem.ashmawi@hc.fm.usp.br
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Joaquim E Vieira, PhD
Organizational Affiliation
Professor
Official's Role
Principal Investigator
12. IPD Sharing Statement
Plan to Share IPD
Undecided
Citations:
PubMed Identifier
15262830
Citation
Selvin E, Erlinger TP. Prevalence of and risk factors for peripheral arterial disease in the United States: results from the National Health and Nutrition Examination Survey, 1999-2000. Circulation. 2004 Aug 10;110(6):738-43. doi: 10.1161/01.CIR.0000137913.26087.F0. Epub 2004 Jul 19.
Results Reference
background
PubMed Identifier
15184277
Citation
Navas-Acien A, Selvin E, Sharrett AR, Calderon-Aranda E, Silbergeld E, Guallar E. Lead, cadmium, smoking, and increased risk of peripheral arterial disease. Circulation. 2004 Jun 29;109(25):3196-201. doi: 10.1161/01.CIR.0000130848.18636.B2. Epub 2004 Jun 7.
Results Reference
background
PubMed Identifier
12719196
Citation
Belch JJ, Topol EJ, Agnelli G, Bertrand M, Califf RM, Clement DL, Creager MA, Easton JD, Gavin JR 3rd, Greenland P, Hankey G, Hanrath P, Hirsch AT, Meyer J, Smith SC, Sullivan F, Weber MA; Prevention of Atherothrombotic Disease Network. Critical issues in peripheral arterial disease detection and management: a call to action. Arch Intern Med. 2003 Apr 28;163(8):884-92. doi: 10.1001/archinte.163.8.884. No abstract available.
Results Reference
background
PubMed Identifier
2673321
Citation
McDaniel MD, Cronenwett JL. Basic data related to the natural history of intermittent claudication. Ann Vasc Surg. 1989 Jul;3(3):273-7. doi: 10.1016/S0890-5096(07)60040-5. No abstract available.
Results Reference
background
PubMed Identifier
9844701
Citation
Marquis P, Lecasble M, Passa P. [Quality of life of patient with peripheral arterial obliterative disease treated with ifenprodil tartrate. Results of an ARTEMIS study]. Drugs. 1998;56 Suppl 3:37-48. doi: 10.2165/00003495-199856003-00005. French.
Results Reference
background
PubMed Identifier
11068220
Citation
Campbell WB, Marriott S, Eve R, Mapson E, Sexton S, Thompson JF. Anaesthesia and analgesia for major lower limb amputation. Cardiovasc Surg. 2000 Dec;8(7):572-5. doi: 10.1016/s0967-2109(00)00071-5.
Results Reference
background
PubMed Identifier
21821511
Citation
Ilfeld BM. Continuous peripheral nerve blocks: a review of the published evidence. Anesth Analg. 2011 Oct;113(4):904-25. doi: 10.1213/ANE.0b013e3182285e01. Epub 2011 Aug 4.
Results Reference
background
PubMed Identifier
18784489
Citation
Capdevila X, Ponrouch M, Choquet O. Continuous peripheral nerve blocks in clinical practice. Curr Opin Anaesthesiol. 2008 Oct;21(5):619-23. doi: 10.1097/ACO.0b013e32830c66c2.
Results Reference
background
Available IPD and Supporting Information:
Available IPD/Information Type
Informed Consent Form
Available IPD/Information URL
http://aplicacao.saude.gov.br/plataformabrasil/visao/pesquisador/gerirPesquisa/gerirPesquisaAgrupador.jsf
Learn more about this trial
Ischemic Pain Control With Analgesic Methods Clinical Trial
We'll reach out to this number within 24 hrs